Head-to-head · Value Score
CoreAge Rx vs SexyMD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, SexyMD a 63. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade B · Good Value
Advertised price
From $79/mo
From $79/mo (compounded semaglutide; confirm total at checkout)
SexyMD
Grade C · Watch List
Advertised price
$269/mo month-to-month on the four-week plan
$269/mo month-to-month on the four-week plan (every headline on the site quotes $199, which is the 48-week commitment rate)
The verdict
CoreAge Rx takes it on Value Score, 81 to 63 — an est. From $79/mo (compounded semaglutide; confirm total at checkout) first month, though we flag its pricing to watch. SexyMD isn't out of it: Shoppers who will read the four-week column of the price table rather than the headline, and who want the state exclusions named before starting.
CoreAge Rx is a featured partner of this site. Its advertised prices have checkout conditions, and state eligibility is confirmed during intake.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | SexyMD |
|---|---|---|
| Value Score | 81 (B) | 63 (C) |
| Advertised price | From $79/mo (compounded semaglutide; confirm total at checkout) | $269/mo month-to-month on the four-week plan (every headline on the site quotes $199, which is the 48-week commitment rate) |
| Save vs brand self-pay | — | — |
| Semaglutide | From $79/mo (compounded injection; confirm total at checkout) | $269/mo month-to-month on the four-week plan (every headline on the site quotes $199, which is the 48-week commitment rate) |
| Tirzepatide | From $129/mo (compounded injection; confirm total at checkout) | $369/mo month-to-month on the four-week plan (the $299 headline is the 48-week rate) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | U.S., state limits shown at intake | 47 states — not Arkansas, Mississippi or New Jersey |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.
What's good
- CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
- CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
- The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
- CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
- CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
- CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.
The fine print
- CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
- CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
- CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
- CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
- CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
- CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.
SexyMD
Compounded semaglutide at $269 a month and tirzepatide at $369, headlined everywhere on the site as $199 and $299 — the rates for committing to forty-eight weeks.
What's good
- The whole ladder is published on the product pages before any intake: $269, $249, $229 and $199 for semaglutide across four, twelve, twenty-four and forty-eight weeks, and $369, $349, $329 and $299 for tirzepatide
- The exclusions are named. One line in the footer says the service is available in all states except three, listed by name — which is the useful half of the coverage statement
- Both pharmacy classes are disclosed in the terms, 503A pharmacies and 503B outsourcing facilities, with what each is regulated by
- A medical practice and a named physician stand behind the prescribing, identified in the terms rather than described as a category
- Cancellation is through the account dashboard or by contacting support, forty-eight hours before the next renewal, and the mechanism is stated once
- Two low-dose products are sold at published prices rather than hidden behind an eligibility check
The fine print
- Every headline on the site is the forty-eight-week rate. "From $199 per month" is what a buyer pays after committing to nearly a year; the month-to-month rate is $269, a difference of $840 over a year
- The asterisk attached to that headline resolves to no footnote anywhere on the page
- The same footer block, on every page of the site, says both that the service is available in all fifty states and that it is available in all states except three. Both sentences are printed together
- The twenty-four- and forty-eight-week tiers print a per-month price while shipping quarterly, and the terms defer the actual charge amount and cadence to the checkout — so whether it is one charge, four or twelve is unpublished
- The two low-dose products price four, eight and twelve weeks identically, in the same table format that carries real tiers on the full-dose pages, so a plan-length table appears where no plan-length discount exists
- Three social-proof figures disagree with each other across the site, and the checkout claims two patient counts for a single day that together exceed the site's own badge by more than thirty times
- A scarcity countdown at the checkout reads that only one discount is left and reserves it for twenty-five minutes, resetting for each new session
- One low-dose page contradicts itself on dosing frequency in its own body copy against its own instructions
- The only phone number on the site is a vanity string in the terms with no digits given, and no pharmacy is named
- What the price includes is never itemized: consultation, shipping, supplies and dose escalation appear on no product page
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to SexyMD.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.